Cigarette Smoking Increases Oxidative Stress in Prostate Cancer Patients – A Preliminary Study by Freitas, Mariana et al.
©2007 by MEDIMOND S.r.l. 51HX10C0069
Cigarette Smoking Increases Oxidative Stress
in Prostate Cancer Patients –
A Preliminary Study
M. Freitas1,2,3, I. Baldeiras3,4, T. Proença3,4, R. Pascoal4, C. Rabaça1,5,
F. Valido6, A. Mota-Pinto1,2 and A. Sarmento-Ribeiro2,3,7
1General Pathology Institute, Faculty of Medicine, University of Coimbra, Portugal
2Investigation Center of Environment,
Genetics and Oncobiology (CIMAGO), Coimbra, Portugal
3Center of Neurosciences and Cell Biology (CNC), Coimbra, Portugal
4Hospital of the University of Coimbra, Portugal
5Portuguese Institute of Oncology, Urology, Coimbra, Portugal
6Portuguese Institute of Oncology, Clinical Pathology, Coimbra, Portugal
7Biochemistry Institute, Faculty of Medicine, University of Coimbra, Portugal
Summary
Cigarette smoke is an oxidant, creating free radicals that are involved in
carcinogenesis namely in Prostate Cancer (PC). However, a correlation be-
tween cigarette smoking and PC progression remains unclear.
This study was directed to evaluate the correlation between cigarette smoking,
Oxidative Stress (OS) and PC development and progression. The Total Anti-
oxidant Status (TAS), Glutathione (GSH) and Malondialdehyde (MDA) were
analysed in the plasma and/or in the erythrocytes of PC patients, 5 smokers
and 9 non-smokers and in controls, 2 smokers and 4 non-smokers.
Our results show a significantly decrease in TAS and GSH, and an in-
crease in MDA levels, in PC smoker group. These results suggest that ciga-
rette smoking may be involved in prostate carcinogenesis.
Introduction
PC is the most frequently diagnosed neoplasm and the second leading
cause of cancer-related mortality in men (1). OS, resulting from the imbalance
between the Reactive Oxygen Species (ROS) and the anti-oxidants system, in
favour of the oxidants, has been linked to PC development and progression
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(2). ROS play an essential role in the regulation of cell signalling. However,
an increase of ROS requires an adaptation in the antioxidant system, other-
wise, may cause damage on biomolecules such as DNA, lipids and proteins
that are implicated in a several number of diseases including cancer. The
antioxidant system comprises enzymes such as superoxide dismutase, cata-
lase, glutathione peroxidase and glutathione S-transferase (GST), and also
other molecules, such as vitamins E and C and GSH. ROS may result from
intracellular generation or from external factors as cigarette smoke (3). Smok-
ing as been linked to an increase of PC risk, in individuals with P1 Ile105val
polymorphism in GST gene, that codifies an enzyme involved in the detoxi-
fication of carcinogens. These compounds comprises Polyaromatic Hydrocar-
bons (PAHs) derived from several combustions including cigarette smoke (4).
On the other hand, PAHs induce thyroide cancer cells proliferation (5) and
increase metalloproteinase expression in PC cells (6). However, a correlation
between smoking and PC development remains unclear.
Taking these results together, it seams plausible that smoking may be
implicated in OS modulation and in prostate carcinogenesis.
We are interested to investigate the correlation between cigarette smoking,
OS and PC development and progression. To approach our goal we provided
this preliminary study, based in the determination of TAS, GSH levels, and
lipid peroxidation in PC patients.
Materials and Methods
Blood samples: All samples were obtained from the Portuguese Institute
Oncology of Coimbra and patients had consented to participate in the study.
This work was performed in the plasma and/or in the erythrocytes of 14 PC
patients, 5 smokers and 9 non-smokers and in 6 controls, 2 smokers and 4
non-smokers.
GSH quantification: Plasmatic levels of GSH were determined by spec-
trophotometry using the assay kit from OxisResearch, according to manufac-
turer’s instruction based on the formation of a cromophoric thione directly
proportional to GSH.
TAS evaluation: TAS was evaluated by a chromogenic method using a
commercially available kit from Randox Laboratories Crumham’s.
Lipid peroxidation measurements: Levels of lipid peroxidation were
measured by the formation of a thiobarbituric acid (TBA) adduct of
malodialdehyde (MDA), separated by HPLC according to Draper & Hadley
(7).
Results
We found a significant increase in lipid peroxidation indicated by MDA
levels and a decrease in TAS and GSH in the PC smoker group compared
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with non-smokers (Fig. 1-A, B, C). The alteration in these parameters are
more pronounced in patients with metastasis (data not shown), which are in
agreement with those obtain by Yossepowitch (8). However, in healthy con-
trol group, non significant differences between smokers and non smokers are
detected (Fig 1-D).
Our results suggest that cigarette smoking an OS may be both implicated
in PC development and progression. However, these results must be con-
firmed with an enlarged sample size.
Figure 1: Effect of cigarette smoking on OS parameters in PC patients and controls. The OS
parameters are analysed in peripheral blood of prostate cancer patients, PC, (A, B, C) and
in healthy controls (D), smokers and non smokers. Values represent the arithmetic means ±
SD of separate experiments. Significant differences between smokers and non smokers are
according to student’s t-test at least p<0,05 (*). PC smoker group show a significant de-
crease of glutathione and TAS in serum (A and C, respectively), and an increase of MDA in
erythrocytes (B).
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Conclusions
PC patients, and in particular PC smoker individuals, are subject to higher
OS, resulting in oxidative damage as determined by serum lipids peroxidation.
This evidence may be related with the decrease of GSH and TAS. Our results
suggest that cigarette smoking and OS may be involved in PC development
and progression. However, these observations need to be confirmed by large-
scale studies.
This work is supported by the Investigation Center of Environment, Genet-
ics and Oncobiology (CIMAGO).
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